Recent Publications by Oncotest GmbH: |  |
Tissue microarrays of human tumor xenografts: characterization of proteins involved in migration and angiogenesis for applications in the development of targeted anticancer agents.
As new target-directed anticancer agents emerge, preclinical efficacy... | 7th February, 2009
| Institute for Experimental Oncology, Oncotest GmbH, Freiburg, Germany.
| Cancer Genomics Proteomics. 2008 Sep-Oct;5(5):263-73.
|
Molecular analysis of xenograft models of human cancer cachexia--possibilities for therapeutic intervention.
Approximately 50% of all cancer patients develop cachexia, a... | 6th December, 2007
| Institute for Experimental Oncology, Oncotest GmbH, Am Flughafen 12-14,
| Cancer Genomics Proteomics. 2007 May-Jun;4(3):223-31.
|
Gene signatures developed from patient tumor explants grown in nude mice to predict tumor response to 11 cytotoxic drugs.
Patient tumor explants established subcutaneously in serial passage in... | 6th December, 2007
| Oncotest GmbH, Institute for Experimental Oncology, Am Flughafen 12-14,
| Cancer Genomics Proteomics. 2007 May-Jun;4(3):197-209.
|
Gene signature-based prediction of tumor response to cyclophosphamide.
Cyclophosphamide (CY) is a clinically used cytotoxic agent that is... | 6th December, 2007
| Oncotest GmbH, Institute for Experimental Oncology, Am Flughafen 12-14,
| Cancer Genomics Proteomics. 2007 May-Jun;4(3):187-95.
|
Microarrays of 41 human tumor cell lines for the characterization of new molecular targets: expression patterns of cathepsin B and the transferrin receptor.
In recent years the use of the microarray technology has allowed the... | 23rd May, 2007
| Institute for Experimental Oncology, Oncotest GmbH, Freiburg, Germany.
| Oncology. 2006;71(1-2):86-94. Epub 2007 Mar 8.
DOI Direct Link |
→View more Oncotest GmbH research publications. |
This page has been viewed 862 times since April 2007, the link to the organisation's website has been followed 0 times